Leukemia Research

Papers
(The H4-Index of Leukemia Research is 15. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Editorial Board35
Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia34
Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling24
Outcomes with high dose cytarabine and mitoxantrone induction for adults with mixed phenotype acute leukemia22
Editorial Board20
TARGETED THERAPY INCREASES PD-L1 PROTEIN EXPRESSION IN CELL LINES OF MEDIASTINAL LYMPHOMA18
Exploring the pathogenesis of extranodal natural killer/T cell lymphoma complicated With EBV via microarray data analysis17
SOX11 AND EPSTEIN–BARR VIRUS MAY SUBSTITUTE EACH OTHER IN EARLY PATHOGENESIS OF BURKITT LYMPHOMA17
ASSEMBLING A RARE NON-HODGKIN LYMPHOMA COHORT: EARLY FINDINGS FROM “THE UMBRELLA STUDY”17
DONOR-DERIVED B-LYMPHOBLASTIC LYMPHOMA FOLLOWING RENAL TRANSPLANT: A CASE REPORT17
Changing frontline AML treatment patterns from 2013 to 202216
EFFICACY AND SAFETY OF SEQUENTIAL DIFFERENT B CELL ANTIGEN-TARGETED CAR T-CELL THERAPY FOR PEDIATRIC REFRACTORY/ RELAPSED BURKITT LYMPHOMA WITH SECONDARY CENTRAL NERVOUS SYSTEM INVOLVEMENT16
Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: HIGHER LEPTIN LEVEL IS ASSOCIATED WITH MYELODYSPLASTIC SYNDROME: A COMPARATIVE STUDY16
Topic: AS01-Diagnosis/AS01a-Cytomorphology: ARTIFICIAL INTELLIGENCE MAY HELP THE HEMATOPATHOLOGIST IN EVALUATION OF BONE MASS AND CELLULARITY IN BONE MARROW SPECIMENS OF PATIENTS WITH MDS15
How low can you go?: Methodologic considerations in clonal hematopoiesis variant calling15
Topic: AS04-MDS Biology and Pathogenesis/AS04a-Normal, MDS, and leukemic stem cells: DER(1;7)(Q10;P10) DEFINES A DISTINCT SUBTYPE OF MYELODYSPLASIA15
MDS AND AUTO-IMMUNITY15
5-AZACYTIDINE IN COMBINATION WITH A NOVEL PAN-LYSYL OXIDASE INHIBITOR SYNERGISTICALLY RESTORES ERYTHROPOIESIS IN MYELODYSPLASTIC MALIGNANCIES15
Topic: AS04-MDS Biology and Pathogenesis/AS04i-Microenvironment and stem cell niche: MESENCHYMAL STROMAL CELLS OF THE BONE MARROW NICHE CONTRIBUTE TO THE PROINFLAMMATORY PHENOTYPE OF CMML MONOCYTES TH15
0.14221787452698